- Home
- PACB vs ANGO Comparison
PACB vs ANGO Comparison
Compare PACB & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACB
- ANGO
- Stock Information
- Founded
- PACB 2000
- ANGO 1988
- Country
- PACB United States
- ANGO United States
- Employees
- PACB N/A
- ANGO N/A
- Industry
- PACB Biotechnology: Laboratory Analytical Instruments
- ANGO Medical/Dental Instruments
- Sector
- PACB Industrials
- ANGO Health Care
- Exchange
- PACB Nasdaq
- ANGO Nasdaq
- Market Cap
- PACB 369.5M
- ANGO 400.8M
- IPO Year
- PACB 2010
- ANGO 2004
- Fundamental
- Price
- PACB $1.41
- ANGO $11.05
- Analyst Decision
- PACB Buy
- ANGO Strong Buy
- Analyst Count
- PACB 7
- ANGO 3
- Target Price
- PACB $1.90
- ANGO $19.33
- AVG Volume (30 Days)
- PACB 6.8M
- ANGO 587.8K
- Earning Date
- PACB 11-06-2025
- ANGO 10-02-2025
- Dividend Yield
- PACB N/A
- ANGO N/A
- EPS Growth
- PACB N/A
- ANGO N/A
- EPS
- PACB N/A
- ANGO N/A
- Revenue
- PACB $156,110,000.00
- ANGO $300,718,000.00
- Revenue This Year
- PACB $6.17
- ANGO $7.42
- Revenue Next Year
- PACB $15.63
- ANGO $6.36
- P/E Ratio
- PACB N/A
- ANGO N/A
- Revenue Growth
- PACB N/A
- ANGO 2.73
- 52 Week Low
- PACB $0.85
- ANGO $5.99
- 52 Week High
- PACB $2.72
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- PACB 51.90
- ANGO 55.56
- Support Level
- PACB $1.39
- ANGO $10.78
- Resistance Level
- PACB $1.60
- ANGO $12.76
- Average True Range (ATR)
- PACB 0.10
- ANGO 0.52
- MACD
- PACB 0.02
- ANGO -0.05
- Stochastic Oscillator
- PACB 48.15
- ANGO 27.12
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.